Skip to content

Drug interactions

Olaparib + Temozolomide

Severity: Major

Olaparib and Temozolomide: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both drugs cause bone marrow suppression, and combining a PARP inhibitor with an alkylating agent substantially increases the frequency and duration of cytopenias. This can lead to infections, bleeding, or the need for dose delays and reductions.

What this interaction means in plain words

Olaparib and Temozolomide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Olaparib belongs to Oncology; Temozolomide belongs to Oncology.

Evidence level: Moderate

Why it happens

Additive myelosuppression; PARP inhibition impairs repair of DNA damage caused by temozolomide.

What to do

Monitor complete blood counts frequently and reduce doses or interrupt treatment for grade 3-4 cytopenias. Use only within a defined regimen with dose-adjustment guidance.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Olaparib and Temozolomide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Olaparib with Temozolomide?

MediHelp rates the interaction as major. Olaparib and Temozolomide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Both drugs cause bone marrow suppression, and combining a PARP inhibitor with an alkylating agent substantially increases the frequency and duration of cytopenias. This can lead to infections, bleeding, or the need for dose delays and reductions.

How serious is the interaction between Olaparib and Temozolomide?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor complete blood counts frequently and reduce doses or interrupt treatment for grade 3-4 cytopenias. Use only within a defined regimen with dose-adjustment guidance.

What other medicines interact with Temozolomide?

MediHelp also lists interactions of Temozolomide with, for example, Adenovirus types 4 and 7 live, Belatacept, Deferiprone. The full list is on the Temozolomide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in